Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs

Jan 2023| PMR2121A| Persistence Market Research

Report Highlights

A recent market study published by Persistence Market Research on the vaginal antifungals market offers a global industry analysis for 2017 to 2021 and an opportunity assessment for 2022 to 2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the vaginal antifungals market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the vaginal antifungals market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the vaginal antifungals market in the most comprehensive way for a better understanding of readers.

Key Market Segments

The study on the vaginal antifungals market offers insights divided into four important segments - drug, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

  • Fluconazole
  • Nystatin
  • Flucytosine
  • Clotrimazole
  • Ketoconazole
  • Terbinafine
  • Others

Route of Administration

  • Oral
  • Topical

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Chapter 1 - Executive Summary

The report commences with the executive summary of the vaginal antifungals market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the vaginal antifungals market as well as the key trends influencing the market.

Chapter 2 - Market Overview

Readers can find detailed taxonomy and drug definition/scope /limitations and inclusions and exclusions of the vaginal antifungals market in this chapter, which helps the readers to understand basic information about the vaginal antifungals market.

Chapter 3 - Key Market Trends

This section highlights the key trends influencing the vaginal antifungals market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 4 - Key Success Factors

This section highlights the market context impacting the vaginal antifungals market, which will help readers in understanding promotional strategies, by key manufacturers, key regulations, reimbursement scenario, pipeline analysis, value chain analysis, PESTEL analysis, and Porter’s analysis, that are expected to create a positive impact on the growth of the vaginal antifungals market during the forecast period.

Chapter 5- Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the vaginal antifungals market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the vaginal antifungals market, which include the drivers, restraints, and opportunity analysis.

Chapter 6 - COVID-19 Crisis Analysis

This section provides the current and expected impact of COVID-19 on the vaginal antifungals market.

Chapter 7- Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

This section explains the global market value or size analysis and forecasts for the vaginal antifungals market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022–2032).

Chapter 8- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Drug

Based on the drug, the vaginal antifungals market is segmented into Fluconazole, Nystatin, Flucytosine, Clotrimazole, Ketoconazole, Terbinafine, and others. In this chapter, readers can find information about a detailed analysis of the market by different drugs available in the vaginal antifungals market and their growth over the forecast period.

Chapter 9- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

Based on the route of administration, the vaginal antifungals market is segmented into oral, and topical. In this chapter, readers can find information about a detailed analysis of the market by various routes of administration available in the vaginal antifungals market and their growth over the forecast period.

Chapter 10– Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

Based on the distribution channel, the vaginal antifungals market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In this chapter, readers can find information about a detailed analysis of the market by distribution channels available in the vaginal antifungals market and their growth over the forecast period.

Chapter 11 - Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Region

This chapter explains how the vaginal antifungals market will grow across seven geographic regions, North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa (MEA).

Chapter 12- North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the North American vaginal antifungals market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on drug, distribution channel, route of administration, and country of the vaginal antifungals market in the North American region.

Chapter 13- Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters based on drug, distribution channel, route of administration, and country in the Latin America vaginal antifungals market during 2022-2032.

Chapter 14- Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and the Rest of Europe are included in this chapter.

Chapter 15- East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia vaginal antifungals market through 2032.

Chapter 16- South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia vaginal antifungals market growth over the forecast period.

Chapter 17- Oceania Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter consists of important parameters that have a huge impact on the growth of the vaginal antifungals market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania vaginal antifungals market.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2032
Units considered $ Million
Segments covered By Drug, By Route Of Administration, By Distribution Channel, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA
Companies studied
  • Pfizer Inc.,
  • Lupin Limited,
  • Bausch Health Companies Inc,
  • ANI Pharmaceuticals, Inc.,
  • Hikma Pharmaceuticals Plc,
  • Glenmark Pharmaceuticals Limited,
  • Mycovia Pharmaceuticals, Inc.,
  • Unique Pharmaceuticals,
  • PEPTONIC medical AB,
  • Aurobindo Pharma Limited and Others.

Chapter 18- Middle East and Africa Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter provides information on how the vaginal antifungals market will grow in the major countries in the MEA region, such as GCC Countries, Türkiye, and the rest of MEA during 2022-2032.

Chapter 19- Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the vaginal antifungals market.

Chapter 20- Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the vaginal antifungals market including company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., and Amplyx Pharmaceuticals Inc.

Chapter 21 - Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 22 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the vaginal antifungals market.

  • Table 1 : Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 2 : Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
  • Table 3 : Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 4 : Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Region
  • Table 5 : North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 6 : North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 7 : North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
  • Table 8 : North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 9 : Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 10 : Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 11 : Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
  • Table 12 : Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 13 : Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 14 : Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 15 : Europe Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
  • Table 16 : Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 17 : East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 18 : East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 19 : East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
  • Table 20 : East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 21 : South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 22 : South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 23 : South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration
  • Table 24 : South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 25 : Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 26 : Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 27 : Oceania Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
  • Table 28 : Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Table 29 : Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 30 : Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 31 : Middle East & Africa Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration
  • Table 32 : Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel
  • Figure 1 : Global Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 2 : Global Vaginal Antifungals Market Forecast & Y-o-Y Growth, 2022–2032
  • Figure 3 : Global Vaginal Antifungals Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032
  • Figure 4 : Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Drug
  • Figure 5 : Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug
  • Figure 6 : Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Drug
  • Figure 7 : Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Route of Administration
  • Figure 8 : Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Route of Administration
  • Figure 9 : Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Route of Administration
  • Figure 10 : Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
  • Figure 11 : Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel
  • Figure 12 : Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Distribution Channel
  • Figure 13 : Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Region
  • Figure 14 : Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
  • Figure 15 : Global Vaginal Antifungals Market Attractiveness Analysis 2022–2032, by Region
  • Figure 16 : North America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 17 : North America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 18 : North America Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 19 : North America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 20 : North America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 21 : North America Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 22 : North America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 23 : North America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 24 : North America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 25 : North America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 26 : U.S. Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 27 : Global Vs. U.S. Growth Comparison
  • Figure 28 : U.S. Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 29 : U.S. Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 30 : U.S. Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 31 : Canada Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 32 : Global Vs. Canada. Growth Comparison
  • Figure 33 : Canada Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 34 : Canada Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 35 : Canada Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 36 : Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 37 : Latin America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 38 : Latin America Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 39 : Latin America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 40 : Latin America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 41 : Latin America Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 42 : Latin America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 43 : Latin America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 44 : Latin America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 45 : Latin America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 46 : Mexico Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 47 : Global Vs Mexico Growth Comparison
  • Figure 48 : Mexico Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 49 : Mexico Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 50 : Mexico Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 51 : Brazil Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 52 : Global Vs. Brazil. Growth Comparison
  • Figure 53 : Brazil Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 54 : Brazil Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 55 : Brazil Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 56 : Argentina Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 57 : Global Vs Argentina Growth Comparison
  • Figure 58 : Argentina Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 59 : Argentina Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 60 : Argentina Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 61 : Europe Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 62 : Europe Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 63 : Europe Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 64 : Europe Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 65 : Europe Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 66 : Europe Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 67 : Europe Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 68 : Europe Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 69 : Europe Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 70 : Europe Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 71 : UK Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 72 : Global Vs. UK Growth Comparison
  • Figure 73 : UK Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 74 : UK Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 75 : UK Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 76 : Germany Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 77 : Global Vs. Germany Growth Comparison
  • Figure 78 : Germany Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 79 : Germany Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 80 : Germany Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 81 : Italy Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 82 : Global Vs. Italy Growth Comparison
  • Figure 83 : Italy Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 84 : Italy Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 85 : Italy Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 86 : France Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 87 : Global Vs France Growth Comparison
  • Figure 88 : France Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 89 : France Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 90 : France Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 91 : Spain Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 92 : Global Vs Spain Growth Comparison
  • Figure 93 : Spain Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 94 : Spain Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 95 : Spain Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 96 : Russia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 97 : Global Vs Russia Growth Comparison
  • Figure 98 : Russia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 99 : Russia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 100 : Russia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 101 : BENELUX Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 102 : Global Vs BENELUX Growth Comparison
  • Figure 103 : BENELUX Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 104 : BENELUX Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 105 : BENELUX Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 106 : East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 107 : East Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 108 : East Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 109 : East Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 110 : East Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 111 : East Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 112 : East Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 113 : East Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 114 : East Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 115 : East Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 116 : China Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 117 : Global Vs. China Growth Comparison
  • Figure 118 : China Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 119 : China Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 120 : China Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 121 : Japan Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 122 : Global Vs. Japan Growth Comparison
  • Figure 123 : Japan Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 124 : Japan Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 125 : Japan Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 126 : South Korea Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 127 : Global Vs South Korea Growth Comparison
  • Figure 128 : South Korea Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 129 : South Korea Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 130 : South Korea Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 131 : South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 132 : South Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 133 : South Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 134 : South Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 135 : South Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 136 : South Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 137 : South Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 138 : South Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 139 : South Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 140 : South Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 141 : India Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 142 : Global Vs. India Growth Comparison
  • Figure 143 : India Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 144 : India Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 145 : India Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 146 : Indonesia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 147 : Global Vs. Indonesia Growth Comparison
  • Figure 148 : Indonesia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 149 : Indonesia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 150 : Indonesia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 151 : Malaysia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 152 : Global Vs. Malaysia Growth Comparison
  • Figure 153 : Malaysia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 154 : Malaysia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 155 : Malaysia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 156 : Thailand Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 157 : Global Vs. Thailand Growth Comparison
  • Figure 158 : Thailand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 159 : Thailand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 160 : Thailand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 161 : Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 162 : Oceania Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 163 : Oceania Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 164 : Oceania Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 165 : Oceania Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 166 : Oceania Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 167 : Oceania Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 168 : Oceania Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 169 : Oceania Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 170 : Oceania Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 171 : Australia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 172 : Global Vs. Australia Growth Comparison
  • Figure 173 : Australia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 174 : Australia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 175 : Australia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 176 : New Zealand Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 177 : Global Vs New Zealand Growth Comparison
  • Figure 178 : New Zealand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 179 : New Zealand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 180 : New Zealand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 181 : Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 182 : Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 183 : Middle East & Africa Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 184 : Middle East & Africa Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 185 : Middle East & Africa Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 186 : Middle East & Africa Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 187 : Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 188 : Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022–2032
  • Figure 189 : Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022–2032
  • Figure 190 : Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Country, 2022–2032
  • Figure 191 : GCC Countries Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 192 : Global Vs GCC Countries Growth Comparison
  • Figure 193 : GCC Countries Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 194 : GCC Countries Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 195 : GCC Countries Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 196 : Turkiye Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 197 : Global Vs. Turkiye Growth Comparison
  • Figure 198 : Turkiye Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 199 : Turkiye Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 200 : Turkiye Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 201 : South Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 202 : Global Vs. South Africa Growth Comparison
  • Figure 203 : South Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 204 : South Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 205 : South Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 206 : North Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 207 : Global Vs North Africa Growth Comparison
  • Figure 208 : North Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 209 : North Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 210 : North Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.